Green S Child And Adolescent Clinical Psychopharmacology

The ideal quick reference for the busy mental health clinician seeing younger patients, the Fifth Edition of Green’s Child and Adolescent Clinical Psychopathology has been fully revised by a new team of authors active in clinical practice and resident education. A trusted reference in the field, Green’s continues to provide practical and balanced information on the full range of medications used to treat mental health disorders in children and adolescents.

Written by a preeminent expert on child and adolescent psychopharmacology, the Fourth Edition of this acclaimed reference is a current, authoritative clinical guide to the pediatric use of psychotropic drugs. For each class of drugs, Dr. Green offers practical advice on titration, dosing, maintenance therapy, discontinuation, and management of side effects. This thoroughly updated edition covers all new drugs and new drug formulations, particularly extended-release and "dextro" stimulant preparations. Dr. Green also reviews recent controlled clinical trials and examines current controversies regarding untoward effects of some drugs. Numerous tables—including a new table on atypical antipsychotics—summarize crucial information.

Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. The sixth edition of this classic text continues to provide clinically-oriented information on medications used to treat common mental health conditions and disorders in children and adolescents. The book boasts an accessible style—with even more tables, graphs, and clinical pearls than ever before—that is designed for easy reading and comprehension. Substantially updated with expanded medication coverage for new FDA approved indications, this practical guide is perfect for residents and practitioners in psychiatry and pediatrics, as well as family medicine.

A classic in its field, Child and Adolescent Clinical Psychopharmacology Made Simple offers everything you need to know about the use of psychoactive medications in the treatment of childhood and adolescent psychological disorders in easy-to-understand language. This fully revised and updated fourth edition offers new information on sleep disorders, sleep medication, and substance abuse. You’ll also find up-to-date DSM-5 definitions, information regarding teen use of antidepressants and suicidality, attention deficit/hyperactivity disorder (ADHD) and ADHD medications, bipolar disorder, psychotic episodes and eating disorders in children and adolescents, the use of antipsychotics in children and adolescents, non-medication approaches and adjuncts to medications, and how to assess and treat noncompliance and “breakthrough” symptoms. Also included are fact sheets that clearly delineate frequently prescribed medications for each disorder along with medication side effects and signs of toxicity. For each psychological disorder, the book offers: current diagnostic criteria; treatment indications and contraindications; medication information; and help for monitoring, evaluating, and following up with patients. Whether you are a pediatrician, parent, therapist, educator, or other health care professional, this is the only resource you need to consult for the most recent information on child and adolescent medications and treatment.

The third edition reflects advances in this rapidly growing field and includes the latest research on the psychopharmacological treatment of children. Each chapter has been revised and updated in detail, emphasizing what has been learned since the last edition.

The field of child and adolescent psychopharmacology is rapidly growing, but psychopharmacological treatments for children cannot be straightforwardly extrapolated from adult studies, which presents clinicians with assessment and prescribing challenges. This important book synthesises research findings about drug treatment of a broad range of psychiatric disorders in children, including attention-deficit hyperactivity disorder, obsessive-compulsive disorder, major depression, schizophrenia, bipolar mania, aggression in pervasive developmental disorder, Tourette's syndrome and substance abuse. They examine the issues of tolerability and efficacy, and appropriate use, within a social and developmental context. For each disorder, pharmacotherapy is discussed in the wider context of neurobiology, etiology, diagnosis and treatment. This will be essential reading for all mental health professionals to inform practice and improve patient outcomes.

Psychopharmacology is a dominant treatment in child and adolescent psychiatry with proven benefits to young patients. The authors present topics related to PSYCHOPHARMACOLOGY ISSUES: Ethical issues, Treatment planning, Side effects, Neural correlates, and Pharmacogenomics. They address DRUGS FOR SPECIFIC DISEASES: Anxiety, Depression, Eating disorders, Sleep disorders, Psychosis and Schizophrenia, High-risk for bilpolar and schizophrenia, Bipolar, ADHD, and Autism. Each topic presents an Overview of the Disease or Issue, Empirical evidence for ethical issues, Treatment summaries that include dose ranges, side effects, contraindications, and how the drugs are used specifically for a disorder. Treatment in the presence of co-morbid conditions, Long-term evidence, and Conclusions and Future directions complete the presentations. Clinical vignettes are provided that exemplify the main points of the topic.